Small Enterprise | The Tribune

NEW YORK, Dec. 30, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally acknowledged stockholder rights regulation company, is investigating potential claims in the direction of Design Therapeutics, Inc. (“Design” or the “Agency”) (NASDAQ: DSGN) on behalf of

Continue Reading